Davis Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Davis Capital Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$72	Buy	+2	New	+$68	﹤0.01%	1141

Other funds holding COLL

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

Acorn Financial Advisory Services Reston, Virginia $753M AUM 36.94% 1-Year Est. Return

SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Davis Capital Management's COLL Position: Q2 2026 in Review

Davis Capital Management opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 2 shares worth $72. The stake represents ﹤0.01% of the portfolio and ranks #1141 among its holdings.

38 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Davis Capital Management held 2 shares of Collegium Pharmaceutical worth $72 as of Q2 2026.
Collegium Pharmaceutical was a new Davis Capital Management position in Q2 2026.
Collegium Pharmaceutical made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #1141 holding.
38 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.